...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Not adding up!

"2. You are expecting some jaw-dropping numbers over at Resverlogix with regards to the Covid-19 trial?"

"Different company.  How is this relevant?"

 

IMO its relevent because again IMO RVX is the "grandfather" of Zen Science. Zen seems more like an arm of this science/rvx or vice versa to me & too top it off their both ruled by the same CEO.

If something reflects/comes off well in one company it is a reflection of sorts of the other - how big a reflection, not sure but none the less i feel it is relevant to a point. 

Share
New Message
Please login to post a reply